Pallone Bill that Cracks Down on Anabolic Steroids to Protect Young Athletes Passes U.S. House of Representatives

Sep 15, 2014 Issues: Health Care

WASHINGTON, DC - Today, the U.S. House of Representatives passed H.R. 4771, the “Designer Anabolic Steroid Control Act,” which was introduced by Congressman Frank Pallone, Jr. (NJ-06), Ranking Member of the Energy and Commerce Subcommittee on Health, and Congressman Joe Pitts (R-PA), Chairman of the Subcommittee on Health.  This bill would authorize the Drug Enforcement Administration (DEA) to crack down on bodybuilding products that contain chemical compounds known as anabolic steroids which are often deceptively marketed as dietary supplements.  Senators Sheldon Whitehouse (D-RI) and Orrin G. Hatch (R-UT) introduced a companion bill in the Senate, S. 2012, in February that is currently pending before the Senate Judiciary Committee.

“Designer anabolic steroids can cause serious harm to consumers, as well as young athletes, who may unknowingly be using these products.  Ensuring that they are classified as controlled substances is vital to protecting the public health,” said Pallone.  “My bill will allow the DEA to act quickly to capture these substances before they reach the marketplace and potentially endanger consumers.  I want to thank Chairman Pitts for working with me on this important issue.”

The “Designer Anabolic Steroid Control Act” would close a loophole often exploited by steroid manufacturers to sell products that claim to be all-natural muscle builders when they may actually contain chemically altered versions of anabolic steroids.  Additionally, the bill would immediately place 27 new designer anabolic steroids on the DEA’s list of controlled substances as defined by the Controlled Substances Act.  The bill grants the DEA the authority to temporarily schedule new designer drugs on the controlled substances list, which will allow the DEA to identify and list new chemicals more easily.  Lastly, the bill would create enhanced civil and criminal penalties for importing, manufacturing, or distributing anabolic steroids under false labels.

Congressman Pallone’s legislation is supported by the U.S. Anti-Doping Agency, the American Herbal Products Association, the Consumer Healthcare Products Association, the Council for Responsible Nutrition, the United Natural Products Alliance, and the Natural Products Association, among others.